Conditions: Hypertension, Pulmonary Ventricular Dysfunction, Left
Keywords: Pulmonary Hypertension Left ventricular dysfunction
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 1
Healthy volunteers: no

Brief summary:
The aim of this study is to assess whether oral Riociguat affects the left ventricular contractility and relaxation in patients with pulmonary hypertension associated with left ventricular systolic dysfunction

Detailed description:
Adverse event data will be covered in Adverse events section.

Arms:
arm 1: Participants received a single oral dose of 1 mg riociguat. arm 2: Participants received a single oral dose of 1 mg placebo.

Interventions: intervention 1: Riociguat (Adempas, BAY63-2521) intervention 2: Placebo
Intervention descriptions: intervention 1: 1 mg single oral dose intervention 2: Single oral dose

Protocol document: